TYKERB 250MG TAB

 Description :

TYKERB is a physician recommended medication utilized: 


with the medication capecitabine to treat individuals with bosom disease that is progressed or that has spread to different pieces of the body (metastatic), and: 


that is HER2-positive (tumors that produce a lot of a protein called human epidermal development factor receptor-2), and 


who have just had certain other bosom malignant growth medicines


Side effects :

TYKERB may cause serious side effects, including:

  • heart problems,
    • feeling like your heart is pounding or racing
    • dizziness
    • tiredness
    • feeling lightheaded
    • shortness of breath
      Your healthcare provider should check your heart function before you start taking TYKERB and during treatment.
  • liver problems.
    • yellowing of your skin or the white part of your eyes
    • dark urine
    • pain or discomfort in the right upper stomach area
      Your healthcare provider should do blood tests to check your liver before you start taking TYKERB and during treatment.
  • diarrhea. 
  • lung problems. 
  • severe skin reactions. 

Common side effects of TYKERB in combination with capecitabine or letrozole include:

  • diarrhea
  • red, painful hands and feet
  • nausea
  • rash
  • vomiting
  • inflamed mouth, digestive tract and airways
  • mouth sores
  • headache
  • unusual hair loss or thinning
  • shortness of breath
  • dry skin
  • itching
  • tiredness
  • painful arms, legs and back
  • loss of appetite
  • indigestion
  • nose bleeds
  • nail disorders such as nail bed changes, nail pain, infection and swelling of the cuticles
  • difficulty sleeping.
Aark pharma is one of the  Top Pharmaceutical Distributors in India and supply all and every kinds of medicines in and acress India.
For placing your orders kindly visit www.aarkpharma.com

Comments

Post a Comment

Popular posts from this blog

Hertraz (Trastuzumab): Revolutionizing Breast Cancer Treatment

Image
 Hertraz (Trastuzumab): Revolutionizing Breast Cancer Treatment Introduction: Breast cancer is one of the most prevalent and life-threatening diseases affecting women worldwide. However, significant strides have been made in the field of oncology to develop targeted therapies that improve patient outcomes. Hertraz, a groundbreaking medication based on the monoclonal antibody trastuzumab, has emerged as a game-changer in the treatment of HER2-positive breast cancer. This blog explores the efficacy, benefits, and future prospects of Hertraz in revolutionizing breast cancer treatment. Understanding Hertraz: Hertraz is a therapeutic drug that harnesses the power of trastuzumab, a monoclonal antibody that specifically targets HER2-positive breast cancer cells. HER2-positive breast cancer is characterized by an overexpression of the HER2 protein, which promotes cancer cell growth. By binding to HER2 receptors, Hertraz inhibits the growth and spread of cancer cells while enhancing the effecti
Read more

Midostar-Midostaurin: A Promising Breakthrough in Cancer Treatment

Image
  Introduction: Cancer continues to be a formidable disease, affecting millions of lives worldwide. However, the field of oncology has witnessed significant advancements, leading to the development of targeted therapies that offer new hope for patients. One such breakthrough is Midostar-Midostaurin , a novel medication with immense potential in the treatment of certain types of cancers. In this blog post, we will explore the mechanism of action, clinical applications, and the future prospects of Midostar-Midostaurin. Understanding Midostar-Midostaurin: Midostar-Midostaurin belongs to a class of drugs known as kinase inhibitors. It specifically targets and inhibits certain enzymes called receptor tyrosine kinases, including FLT3 and KIT. These enzymes play a critical role in the growth and proliferation of cancer cells, particularly in acute myeloid leukemia (AML) and aggressive systemic mastocytosis (ASM). Clinical Applications: Acute Myeloid Leukemia (AML): AML is a fast-growing type
Read more

Direct to patient pharmacy

Image
 Making clinical preliminaries more tolerant-driven is among the many difficulties confronting the drug business. One technique for further developing the patient experience is by conveying concentrate taking drugs straightforwardly to patient homes, otherwise called Direct-to-Patient or DTP. Notwithstanding, the execution of Direct-to-Patient might appear to be unrealistic in a profoundly controlled industry where explicit guidelines or direction is missing or ambiguous. Moreover, Direct-to-Patient encounters can be conflicting by nation, preliminary, or helpful region.  Along these lines, in follow up to the peak blog entry, Developing a Guide for Patient-Centric Logistics - Get Involved1 a working together with a group of Direct-to-Patient Sponsors, Couriers, CROS, and QPs will, through a progression of web journals, distinguish a portion of the direct-to-patient models, share contemplations for building up a Direct-to-Patient program according to the partners' point of view and
Read more